> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Oral anticoagulation after AF ablation raised bleeding without fewer ischaemic strokes
- URL: https://www.coios.me/oral-anticoagulation-after-af-ablation-raised-bleeding/
- Published: 2026-11-03T13:02:29.000Z
- Updated: 2026-11-03T17:56:29.000Z
- Description: In 280,415 patients, continuing anticoagulation after AF ablation left ischaemic stroke unchanged but roughly tripled bleeding odds.
- Author: Daniel Ryan
- Tags: Health today, Heart and stroke, World, #peer-reviewed, #refines, #item, #source-2026-11, #score-62

This systematic review and meta-analysis compared continuing versus stopping oral anticoagulation after catheter ablation for atrial fibrillation. It pooled 3 randomised trials and 35 cohort studies, covering 280,415 patients followed for 2.7 years. Net clinical benefit (NCB) weighed ischaemic strokes prevented against intracranial haemorrhages caused, counting each haemorrhage as 1.5 strokes. Pooled, continued anticoagulation left ischaemic stroke similar but raised major bleeding (OR 2.93) and intracranial haemorrhage (OR 3.63). NCB favoured stopping (-0.46; 95% CI -0.77 to -0.14), a negative score meaning net harm from continuing. The trials alone showed no difference on any outcome, so the harm signal rests on observational cohorts.

*Why it is interesting: Anticoagulation after ablation shapes both stroke and bleeding rates in people with atrial fibrillation. The pooled evidence suggests its stroke benefit shrinks after ablation while its bleeding cost remains.*

Source

[Thrombosis and Haemostasis, 2 November 2026](https://doi.org/10.1055/a-2994-8900?ref=coios.me)

Paper

Net Clinical Benefit of Continuing vs Discontinuing Anticoagulation After Atrial Fibrillation Ablation: Results from a 280,000-Patient Meta-Analysis

Authors

Koolaji S, Gorog DA, Leader JH, Markides V

DOI

10.1055/a-2994-8900

Type

Peer-reviewed article

Design

Systematic review and meta-analysis of 38 studies (3 RCTs, 35 cohorts), 280,415 patients, mean 2.7 years' follow-up

Verdict

Refines prior evidence

Driver

[Heart and stroke](https://www.coios.me/d-cardiovascular/)